Insulet | PODD - Ebitda

Stock Price
204.31
Daily Change
-2.73 -1.32%
Monthly
-15.52%
Yearly
-20.44%
Q2 Forecast
198.16

Insulet reported $194M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Abbott USD 3.09B 44M Sep/2025
Align Technology USD 183.84M 19.77M Sep/2025
AtriCure USD 19.86M 2.06M Dec/2025
Avanos Medical USD 10M 73.9M Sep/2025
Baxter International USD 426M 36M Sep/2025
Becton, Dickinson and Co. USD 1.71B 433M Dec/2025
Boston Scientific USD 1.37B 1000K Sep/2025
Cardinal Health USD 981M 5M Dec/2025
Cooper Companies USD 323.4M 13.2M Dec/2025
Dexcom USD 422.2M 53.8M Dec/2025
Edwards Lifesciences USD 464.3M 4.7M Sep/2025
Eli Lilly USD 7.88B 378.1M Sep/2025
Globus Medical USD 280.46M 27.86M Dec/2025
ICU Medical USD 98.19M 27.67M Dec/2025
Insulet USD 194M 34M Dec/2025
Integra LifeSciences USD 104.21M 25.76M Dec/2025
J&J USD 9.52B 389M Sep/2025
Masimo USD 91.9M 19.9M Sep/2025
Medtronic USD 2.93B 482M Dec/2025
Merit Medical Systems USD 97.23M 17.69M Dec/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Solventum Corp USD 437M 38M Dec/2025
Stryker USD 1.67B 206M Sep/2025
Tandem Diabetes Care USD 32.9M 30.13M Dec/2025
Teleflex USD -328.81M 536.43M Sep/2025
West Pharmaceutical Services USD 218.5M 5.4M Dec/2025
Zimmer Biomet Holdings USD 759M 120.8M Dec/2025